HOME >> BIOLOGY >> NEWS
Obesity has reached epidemic proportions - urgent need for research

Every second German is too fat, every fifth even suffers from pathological obesity (adiposity). Obesity is not only a burden, but also causes physical disorders, some of which may prove fatal. The Deutsche Forschungsgemeinschaft (DFG) invited 40 experts from all over the world to a discussion forum entitled "Genetics, Diet and Disease - Consequences of Obesity" at Leipzig University. Under the chairmanship of Prof. Dr. med. Wieland Kiess, Director of Leipzig University's Children's Clinic, the scientists discussed the causes and effects of obesity and defined the areas where research is urgently needed.

The researchers attending the forum called for the development of guidelines to support doctors and patients in their struggle against "obesity", which has now reached epidemic proportions. Research into adiposity must be intensified and individual projects brought into combination; in particular, we know too little about the side-effects and consequences of obesity. Wide-ranging studies of affected families will have to be undertaken to form an adequate basis for scientists addressing these questions. It is also not clear how hereditary predisposition and a person's way of life influence the genesis of obesity; comprehensive molecular-biological research is required for this.

The chairman, Prof. Dr. Kiess, declared that "Obesity is the prime pathological risk factor today". For the obese, the chances of contracting an illness are several times higher than they are for slim people. Fat people are not only threatened by cardiovascular disorders, but also by diabetes, arteriosclerosis and renal disorders. If a hereditary predisposition is exacerbated by additional dietary deficiencies and lack of exercise, then the pounds will accumulate almost inevitably. "Today, it is almost normal to be obese", stated Prof. Claude Bouchard, co-publisher of the International Handbook on Obesity and Adiposity during the meeting in Leipzig. "Early diagnosis and treatment o
'"/>

Contact: Dr. Heike Velke
heike.velke@dfg.de
49-228-885-2341
Deutsche Forschungsgemeinschaft
18-May-2000


Page: 1 2

Related biology news :

1. Obesity and hypertension: Two epidemics or one?
2. Obesity alone not a good predictor of cardiovascular risk and death, fat distribution proved best
3. Obesity drug inhibits prostate tumor growth
4. Obesity and blood pressure
5. Obesity, kidney genetics, erectile dysfunction among highlighted research at APS Meeting
6. Obesity in Costa Rican children alarming, likely future health burden
7. Obesity prevention program aimed at second graders
8. Obesity not a personal failing, but a battle against biology
9. Obesity sleuths find chronic diseases linked to behavior contrary our DNA
10. Obesity...by choice
11. Obesity may exacerbate a heart disorder in African American females

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
(Date:3/16/2017)... Germany , March 16, 2017 CeBIT 2017 - Against identity ... Continue Reading ... Used combined in one project, multi-biometric solutions provide ... Used ... Systems) ...
(Date:3/7/2017)... , March 7, 2017 Brandwatch , the ... by The Prince,s Trust to uncover insights to support ... The Trust. The UK,s leading youth charity will be ... campaign results and get a better understanding of the topics and ... ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017 According to a report ... derivatives market is fragmented due to the presence of a large pool ... Thermo Fisher , and Sigma-Aldrich, compete with each other in ... collectively, held more than 76% of this market in 2016.  ... As of now, a ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced the hire of Dr. Sigmund “Sig” Floyd as Vice President ? ... partnerships and joint development activities. , “Dr. Floyd’s career has spanned 30 years ...
(Date:3/22/2017)... 2017  Ascendis Pharma A/S (Nasdaq: ASND), a ... to address significant unmet medical needs in rare ... year ended December 31, 2016. ... as we broadened our pipeline and pursued our ... company with an initial focus on endocrinology," said ...
(Date:3/22/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused ... announced today that Dr. Miriam Kidron , ... titled, "Oral Insulin for Diabetes Treatment: Bypassing the ... and Peptide Therapeutics (OPT) Boston Conference in ...
Breaking Biology Technology:
Cached News: